A clinical photograph illustrating a patient performing a Pulmonary Function Test (PFT) via spirometry in a clinical or research setting. The image depicts an older adult male seated upright, wearing a nose clip to ensure mouth-only breathing. He is actively interacting with a handheld spirometer, holding the disposable mouthpiece with both hands to maintain a tight seal. The device is connected via a data cable to a computer system, which includes a monitor displaying an active interface, likely for real-time visualization of flow-volume loops and spirograms. On the desk, several replacement white cylindrical mouthpieces and the hardware interface are visible. This visual serves as an educational example of the standardized setup for measuring lung volumes and ventilation capacities, such as Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 second (FEV1), highlighting the necessary equipment and proper patient positioning during the procedure.

This clinical photograph illustrates the performance of a pulmonary function test, specifically Forced Vital Capacity (FVC) measurement, in an aquatic sports setting. A young male subject, wearing a blue swimming cap and dark shorts, is seated while performing spirometry. He is using a handheld digital spirometer (Pocket Spiro USB-100), gripping the white device with both hands. The subject’s lips are tightly sealed around a disposable cylindrical mouthpiece, and a nose clip is applied to ensure isolated oral expiration. A data cable connects the spirometer to a laptop on a nearby table, indicating real-time data acquisition and flow-volume loop analysis. The background shows a swimming pool environment, suggesting clinical research into the respiratory physiology of swimmers or the impact of aquatic training on lung volumes. This image serves as an educational example of portable spirometry application and proper patient positioning for diagnostic respiratory maneuvers outside a traditional lab setting.

Summary : This flowchart outlines the diagnostic pathway for evaluating patients with symptoms suggestive of exercise-induced bronchoconstriction (EIB) using spirometry and the interpretation of FEV1 values, with subsequent steps based on reversibility to beta2 agonists. flowchart: Nodes : • Start: "Symptoms suggestive of EIB" (text) • "Spirometry" (rectangle) • Decision: "FEV1 < 70%" (diamond) • Decision: "FEV1 ≥ 70%" (diamond) • "Reversible airway obstruction consistent with asthma and high risk of EIB" (rectangle, appears twice) • "*Beta2 agonist reversibility" (annotation, appears twice) • "No Beta2 agonist reversibility" (annotation, appears twice) Connectors : • Arrow from "Symptoms suggestive of EIB" to "Spirometry" • Arrow from "Spirometry" splits to "FEV1 < 70%" and "FEV1 ≥ 70%" • From "FEV1 < 70%": – Arrow to "*Beta2 agonist reversibility" leading to "Reversible airway obstruction consistent with asthma and high risk of EIB" – Arrow to "No Beta2 agonist reversibility" (ends) • From "FEV1 ≥ 70%": – Arrow to "*Beta2 agonist reversibility" leading to "Reversible airway obstruction consistent with asthma and high risk of EIB" – Arrow to "No Beta2 agonist reversibility" (ends) Layout : • Linear top-down flow with a split after spirometry into two branches based on FEV1 value (<70% or ≥70%), each with two possible outcomes (reversibility or not). • Annotations for beta2 agonist reversibility are placed before the final diagnostic node in each branch. Analysis : • The flowchart provides a clear, stepwise approach for diagnosing EIB in patients with suggestive symptoms. • Spirometry is the initial test, with FEV1 value determining the next step. • Both FEV1 < 70% and FEV1 ≥ 70% require assessment of reversibility to beta2 agonists to confirm reversible airway obstruction, consistent with asthma and high risk of EIB. • If there is no reversibility to beta2 agonists, the pathway ends without a diagnosis of reversible airway obstruction.

High-resolution computed tomography (HRCT) comparison of interstitial lung disease (ILD) patterns in systemic sclerosis (SSc). Figures A (axial) and B (coronal) display a Non-Specific Interstitial Pneumonia (NSIP) pattern characterized by bilateral, diffuse ground-glass opacities and mild traction bronchiectasis with a distinct basal predominance. Figures C (axial) and D (coronal) demonstrate a Usual Interstitial Pneumonia (UIP) pattern. This pattern is marked by extensive subpleural honeycombing (clusters of cystic airspaces), exuberant traction bronchiectasis, and severe architectural distortion predominantly involving the lower lung zones. These diagnostic images serve to illustrate the distinct radiologic morphology between NSIP and UIP patterns in patients with connective tissue disease-associated ILD, highlighting key features such as distribution, presence of honeycombing, and the degree of fibrotic changes essential for clinical classification and management.

High-resolution computed tomography (HRCT) axial scans of the lung illustrating the progression of Rheumatoid Arthritis-associated Interstitial Lung Disease (RA-ILD) over approximately 3.5 years in two distinct radiographic patterns. The upper row demonstrates a 'Probable Usual Interstitial Pneumonia (UIP)' pattern. Initial scans show baseline reticulation and small subpleural cystic spaces, which progress at the 2-year 6-month and 3-year 5-month marks into extensive, multi-layered honeycombing with significant architectural distortion. The lower row displays a 'Nonspecific Interstitial Pneumonia (NSIP)' pattern. The initial scan shows ground-glass opacities and mild reticulation. Over 3 years and 4 months, there is a transformation into a UIP-like phenotype, characterized by the development of subpleural reticulation, traction bronchiectasis (indicated by arrowheads), and localized peripheral honeycombing. This comparison highlights the natural history of fibrotic progression and the phenotypic 'drift' toward a UIP-like pattern in chronic connective tissue disease-associated ILD, carrying significant prognostic and therapeutic implications.

This composite of four axial high-resolution computed tomography (HRCT) scans illustrates various radiologic patterns of Rheumatoid Arthritis-associated Interstitial Lung Disease (RA-ILD). Panel A demonstrates a Usual Interstitial Pneumonia (UIP) pattern, characterized by bibasilar, subpleural honeycombing (clusters of cystic airspaces), reticular opacities, and traction bronchiectasis. Panel B displays a Nonspecific Interstitial Pneumonia (NSIP) pattern, showing diffuse, patchy ground-glass opacities and septal thickening with relative subpleural sparing. Panel C reveals a Lymphocytic Interstitial Pneumonia (LIP) pattern, highlighted by perivascular thin-walled lung cysts (indicated by black arrows). Panel D illustrates an Organizing Pneumonia (OP) pattern, featuring focal areas of parenchymal consolidation (indicated by a white arrow). These images serve as educational benchmarks for differentiating pulmonary manifestations in systemic autoimmune diseases. The radiological findings are critical for determining prognosis and guiding therapeutic strategies, such as distinguishing between predominantly fibrotic (UIP) versus inflammatory (NSIP/OP) processes.

Educational multi-modal imaging of fibrotic hypersensitivity pneumonitis (Farmer's Lung). (A, B) Axial high-resolution computed tomography (HRCT) of the chest demonstrating key interstitial features. Image A shows a peribronchovascular distribution of reticular opacities (white circle) accompanied by mosaic lung attenuation, suggesting small airway involvement. Image B highlights mild diffuse subpleural reticulations (black arrows). (C, D) Posteroanterior and lateral chest radiographs revealing coarse reticulations and interstitial fibrosis (asterisks) primarily concentrated in the upper lung zones, associated with mild volume loss. A surgical staple line (black arrow in C) is visible in the left lower lobe, representing a prior diagnostic biopsy site. The imaging illustrates the classic presentation of chronic occupational interstitial lung disease, characterized by upper-lobe predominant fibrosis and architectural distortion.

**Imaging Modality:** High-resolution computed tomography (HRCT) of the chest. **Anatomical Region:** Axial section of the thorax at the level of the main bronchi and pulmonary hila. **Observed Pathology:** Hypersensitivity pneumonitis (extrinsic allergic alveolitis). **Characteristic Visual Features:** The image demonstrates diffuse, bilateral ground-glass opacities (GGO) involving both lung fields. There is a prominent pattern of poorly defined centrilobular nodules, which are characteristic of the subacute phase of hypersensitivity pneumonitis. The distribution appears relatively uniform without significant craniocaudal or peripheral sparing in this single slice. No evidence of honeycombing, traction bronchiectasis, or significant architectural distortion is visible, suggesting an absence of advanced fibrosis. The bronchial structures and mediastinal contours appear within normal limits for this section. **Key Diagnostic Features:** The combination of widespread ground-glass attenuation and subtle centrilobular nodularity is highly suggestive of an inflammatory interstitial lung disease, specifically hypersensitivity pneumonitis triggered by inhaled organic antigens. These findings assist in differentiating the condition from other interstitial pneumonias or acute alveolar processes.

This composite diagnostic image illustrates the identification and interventional management of a solitary pulmonary nodule, identified as a lung metastasis. Panel A (frontal) and Panel B (lateral) are chest X-rays demonstrating a well-defined, rounded soft tissue opacity—often termed a 'coin lesion'—located in the mid-zone of the left lung. Panel C provides a corresponding high-resolution axial CT scan in lung-window setting, confirming a solitary, hyperdense, peripheral mass with distinct margins in the posterior segment of the left lung. Panel D shows an axial CT image of the patient in the prone position during a CT-guided percutaneous needle biopsy. A biopsy needle is clearly visible traversing the posterior chest wall and terminating within the target lesion. This educational series demonstrates the clinical pathway from radiological detection via X-ray to diagnostic characterization using CT and definitive tissue sampling. The case highlights staging protocols for metastatic disease, particularly relevant in oncology for determining disease progression and treatment planning.

Diagnostic axial chest CT scan in lung windows demonstrating a solitary pulmonary nodule in the right lower lobe. Image A provides a broad overview of the lower thorax at the level of the diaphragm, where a white arrow indicates a 17 x 15 mm peripheral opacity. Image B presents a magnified view of the same lesion (circled), allowing for detailed assessment of its morphology. The nodule is located in the medial aspect of the lung base, adjacent to the right diaphragmatic crus. Visually, the lesion is well-defined but exhibits slightly irregular or lobulated margins with heterogeneous internal density relative to the surrounding aerated lung parenchyma. In a clinical context of ACTH-dependent Cushing syndrome, such a finding is highly significant as a potential source of ectopic ACTH secretion. This image serves as a teaching tool for identifying small solitary pulmonary nodules and emphasizes the importance of magnification in characterizing nodule margins and internal structure for oncological and endocrinological workups.

Summary : This figure presents a comprehensive flowchart algorithm for the evaluation and management of chronic spinal pain, detailing the stepwise process from initial assessment through re-evaluation and ongoing management. flowchart: # Nodes : • Evaluation and Management (rectangle) • History (rectangle): Pain history, Medical history, Psychosocial history • Assessment (rectangle): Physical examination, Functional assessment, Psychosocial assessment, Diagnostic testing • Impression (rectangle) • Management plan (rectangle) • Medical and rehabilitation therapies (rectangle) • Diagnostic interventions (rectangle) • Therapeutic interventional management (rectangle) • Re-evaluation (rectangle) • Persistent pain, New pain, Worsening pain (rectangle) • Repeat comprehensive evaluation (rectangle) • Adequate pain relief and improvement in functional status (rectangle) • Continue therapeutic management (rectangle) # Connectors : • Top-down arrows connect each step sequentially. • After "Management plan," three branches lead to "Medical and rehabilitation therapies," "Diagnostic interventions," and "Therapeutic interventional management." • All three branches converge at "Re-evaluation." • "Re-evaluation" splits into two branches: – Left: "Persistent pain, New pain, Worsening pain" → "Repeat comprehensive evaluation" – Right: "Adequate pain relief and improvement in functional status" → "Continue therapeutic management" # Layout : • Vertically oriented flowchart with multiple parallel branches at the management plan stage. • Merging and splitting of branches at re-evaluation, forming a decision point. • All nodes are rectangles with shadow effects for emphasis. # Analysis : • The flowchart provides a systematic, iterative approach to chronic spinal pain management. • Initial steps focus on thorough history and assessment, followed by formulation of an impression and management plan. • Management options are divided into medical/rehabilitation, diagnostic, and interventional therapies. • Re-evaluation is a critical decision point: persistent or worsening pain triggers a repeat evaluation, while adequate relief leads to continued management. • The algorithm emphasizes ongoing assessment and adaptation of treatment based on patient response.

Summary : This flowchart presents an algorithm for the management of patients with suspected or confirmed ruptured abdominal aortic aneurysm (rAAA), outlining recommended time goals and stepwise clinical decision-making from emergency department arrival to surgical intervention. flowchart: # Nodes : • "Evaluation by an Emergency Physician of Any Patient Suspected of Having a Ruptured AAA" (rectangle) • "Diagnosis" (rectangle) • "Immediate Management" (rectangle) • "Consideration of Transfer to Regional Center" (rectangle) • Decision node: "If appropriate vascular services cannot be provided" (diamond; Yes/No branches) • "Rapid Transfer" (rectangle; Yes branch) • "Emergent Evaluation by Receiving Vascular Surgery Team" (rectangle; Yes branch) • "Emergent In-house Vascular Surgery Evaluation" (rectangle; No branch) • "Intervention by Vascular Surgery Team" (rectangle; both Yes/No branches converge here) # Connectors : • Downward arrows connect each step sequentially. • From "Consideration of Transfer to Regional Center", a decision diamond splits into: – Yes: proceeds to "Rapid Transfer" → "Emergent Evaluation by Receiving Vascular Surgery Team" – No: proceeds to "Emergent In-house Vascular Surgery Evaluation" • Both branches converge at "Intervention by Vascular Surgery Team". # Layout : • Vertical flow, top-to-bottom. • Decision diamond creates two parallel branches (Yes/No) that reconverge. • Time goals indicated on the left: "Emergency Department Door to Intervention = Less than 90 Minutes", with 30-minute intervals for each major step. # Section Details : ## Evaluation by Emergency Physician : • Airway, Breathing, Circulation (ABC) protocol. • General assessment. • Vital sign monitoring. ## Diagnosis : • Clinical diagnosis criteria: Age > 50 with abdominal/back pain AND hypotension; known AAA with symptoms; hypotension or impending cardiovascular collapse. • Radiologic confirmation (ultrasound or CT) only if alternative diagnosis is likely. • Lab work/x-rays only to confirm rAAA. ## Immediate Management : • IV access with two large bore peripheral IVs. • Permissive hypotension (mental status and systolic pressure 70–90 mmHg). • Lab/x-ray only to confirm diagnosis. ## Consideration of Transfer to Regional Center : • Transfer if appropriate vascular services unavailable. • Transfer patients with good functional status and without severe comorbidity. • Patients who previously declined elective surgery should still be considered. • Discuss with receiving vascular surgeon: goals of care, comorbidities, hemodynamics. • Contraindication: ongoing cardiac arrest. ## Rapid Transfer (Yes branch) : • Physician-to-physician phone handoff. • Transfer images with patient if obtained. • In-transit care: vital sign monitoring, permissive hypotension. ## Emergent Evaluation by Receiving Vascular Surgery Team (Yes branch) : • Immediate evaluation upon arrival. ## Emergent In-house Vascular Surgery Evaluation (No branch) : • Immediate evaluation by in-house team. ## Intervention by Vascular Surgery Team : • Final step for both transfer and in-house pathways. # Design Encodings : • Rectangular nodes for process steps. • Diamond node for decision point. • Bold red vertical bar on left indicating time goals. • Arrows for flow direction. • Text box at bottom: "Fig 5. Algorithm for management of the patient with a suspected or confirmed ruptured abdominal aortic aneurysm (AAA). CT, Computed tomography; IVs, intravenous lines." # Analysis : • The algorithm emphasizes rapid assessment, diagnosis, and management, aiming for intervention within 90 minutes of emergency department arrival. • Decision logic prioritizes transfer to specialized centers if vascular services are unavailable, with clear criteria for transfer and contraindications. • Both transfer and in-house pathways converge on emergent surgical intervention, underscoring the urgency and standardized approach to rAAA management. • Time goals are visually reinforced, highlighting the importance of minimizing delays at each step.

This composite diagnostic image compares pre-treatment and post-treatment thoracic imaging in a patient with allergic bronchopulmonary aspergillosis (ABPA). Pre-treatment imaging (1-A, 1-B, 1-C) includes a posterior-anterior chest X-ray showing right middle lobe consolidation (black arrow) and scattered bilateral nodular opacities. Corresponding axial CT scans demonstrate bilateral central bronchiectasis, characteristic 'finger-in-glove' mucus impaction (yellow arrow), and areas of segmental/subsegmental atelectasis (yellow star). Post-treatment imaging (4-A, 4-B, 4-C) after steroid therapy reveals significant interval improvement. The chest X-ray (4-A) shows complete resolution of the right middle lobe consolidation. The follow-up axial CT scans (4-B, 4-C) demonstrate the clearance of mucus impaction and resolution of atelectasis, though residual cylindrical central bronchiectasis (yellow arrows) remains visible. This comparison illustrates the typical radiological progression and therapeutic response of mucoid impaction and secondary lung collapse in inflammatory airway disease.

This composite diagnostic image features a side-by-side comparison of a chest X-ray (left) and a computed tomography (CT) scan (right) from a patient with Allergic Bronchopulmonary Aspergillosis (ABPA). The chest X-ray demonstrates increased reticular opacities and areas of consolidation, particularly concentrated in the lower lobes, which are characteristic of chronic inflammatory changes and infection. The axial CT scan on the right provides a more detailed view of the lung parenchyma, highlighting significant bronchial dilation consistent with bronchiectasis. A key diagnostic feature shown is mucus impaction within the dilated airways, creating the classic 'finger-in-glove' appearance, where dense mucoid material fills the bronchial lumen. These findings illustrate the typical radiographic progression of ABPA, showing the relationship between airway remodeling (bronchiectasis) and functional obstruction (airway impaction) in the context of a hypersensitivity response to Aspergillus species.

A composite of three clinical photographs demonstrating the classic cutaneous manifestations of dermatomyositis, an idiopathic inflammatory myopathy. Panel A: A heliotrope rash characterized by a reddish-purple (violaceous) discoloration in the periorbital region, involving the eyelids and malar area. Panel B: Gottron papules/sign, presenting as erythematous to violaceous, slightly scaly patches overlying the dorsal aspect of the metacarpophalangeal and interphalangeal joints. Panel C: The 'V-sign,' a confluent erythematous rash in a photosensitive distribution across the anterior lower neck and upper chest. These findings are pathognomonic for dermatomyositis and are critical for clinical diagnosis, often preceding or accompanying proximal muscle weakness. The images highlight key dermatologic markers used to differentiate dermatomyositis from other connective tissue diseases and inflammatory myopathies like polymyositis.

This clinical photograph displays the anterior neck, upper chest, and shoulders of a patient with dermatomyositis. The image highlights a confluent erythematous rash in a characteristic 'shawl sign' distribution. The skin appears mottled with varying intensities of redness, ranging from discrete maculopapular lesions to confluent patches covering the sun-exposed areas. A small, circular mark representing a recent skin punch biopsy site is visible on the upper left chest wall. This visual presentation is a hallmark cutaneous manifestation of inflammatory myopathies, illustrating the photosensitive nature of the condition. It serves as an educational example for dermatological and rheumatological assessment in patients presenting with symmetrical proximal muscle weakness and systemic symptoms.

Summary : This flowchart outlines the diagnostic and management pathway for suspected Obesity Hypoventilation Syndrome (OHS), differentiating between ambulatory and hospitalized obese patients, and guiding subsequent investigations and treatments based on probability, laboratory findings, and response to therapy. flowchart: # Nodes : • Suspected OHS† (rounded rectangle, start) • Ambulatory stable obese patient (rectangle) • Hospitalized obese patient with hypercapnic respiratory failure (rectangle) • High probability of OHS (rectangle) • Low/moderate probability of OHS (rectangle) • Serum bicarbonate ≥27 mmol/l (rectangle) • Serum bicarbonate <27 mmol/l (rectangle) • Perform ABG (rectangle) • OHS highly unlikely (rectangle) • Hypercapnia confirmed? (diamond/decision) • Yes (rectangle) • No (rectangle) • Sleep study/PAP titration (rectangle) • Initiate NIV treatment (rectangle) • Discharge with NIV not feasible* (rectangle) • NIV with empiric settings recommended at hospital discharge* (rectangle) • Perform other studies or treatments (rectangle) • Sleep study/PAP titration within 3 months (rectangle) • OHS Confirmed (rectangle) • OHS not confirmed (rectangle) • OHS and severe OSA (rectangle) • OHS with no OSA or mild/moderate OSA (rectangle) • CPAP titration and treatment (rectangle) • NIV titration and treatment (rectangle) • Case-by-case assessment (rectangle) • Adequate treatment of OHS (rectangle) • Inadequate treatment of OHS (rectangle) • Consider bariatric surgery (rectangle) • Continue CPAP therapy (rectangle) • Change to NIV therapy (rectangle) # Connectors : • Downward arrows connect each step in the process. • Branches split based on probability of OHS, serum bicarbonate levels, and confirmation of hypercapnia. • Decision diamond at "Hypercapnia confirmed?" splits to "Yes" (proceed to sleep study/PAP titration) or "No" (OHS highly unlikely or further studies/treatments). • Hospitalized patient pathway splits to "Discharge with NIV not feasible*" or "NIV with empiric settings recommended at hospital discharge*", then to "Sleep study/PAP titration within 3 months" or "Perform other studies or treatments". • After sleep study/PAP titration, branches to "OHS Confirmed" or "OHS not confirmed". • If OHS confirmed, further split into "OHS and severe OSA" (CPAP titration/treatment) or "OHS with no OSA or mild/moderate OSA" (NIV titration/treatment). • Case-by-case assessment leads to either "Adequate treatment of OHS" (continue CPAP therapy or consider bariatric surgery) or "Inadequate treatment of OHS" (change to NIV therapy or consider bariatric surgery). # Layout : • The flowchart is organized in a top-down manner, starting with suspected OHS and splitting into two main branches: ambulatory stable obese patients and hospitalized obese patients. • Each branch contains further decision points and merges at the sleep study/PAP titration step. • The chart uses rectangles for process steps, a diamond for decision, and rounded rectangles for start/end points. • Blue-shaded boxes indicate steps involving sleep study/PAP titration and treatment decisions. # Analysis : • The flowchart provides a clear, stepwise approach for evaluating and managing suspected OHS, emphasizing the importance of serum bicarbonate and ABG testing in ambulatory patients, and NIV initiation in hospitalized patients. • Decision points ensure that only patients with confirmed hypercapnia proceed to sleep study/PAP titration. • The pathway distinguishes between OHS with severe OSA (managed with CPAP) and OHS with no/mild/moderate OSA (managed with NIV). • Case-by-case assessment allows for individualized management, including consideration of bariatric surgery for refractory cases. • The chart highlights the need for follow-up sleep studies and titration within 3 months for hospitalized patients discharged on NIV.

This infographic combines a clinical photograph of a historical statue (Bacchus in Boboli Gardens) with descriptive text boxes to illustrate the systemic consequences of obesity and Obesity Hypoventilation Syndrome (OHS). The central visual features a male figure with morbid obesity, characterized by significant central abdominal fat, subcutaneous fat around the thorax and thighs, and visible skin folds, seated on a tortoise. Surrounding the figure are clinical annotations categorized by organ system: 'Central Nervous System' (cognitive deficit, decreased neuronal drive), 'Upper Airway' (obstructive sleep apnea, intubation risk), 'Metabolic' (metabolic syndrome, chronic inflammation, IGF-1 deficit), 'Respiratory' (restrictive lung function, pulmonary hypertension, hypercapnia/hypoxemia), 'Cardiovascular' (endothelial dysfunction, coronary artery disease, chronic heart failure), and 'General' (peripheral edema, decreased physical activity, increased morbi-mortality). This educational illustration serves as a pathophysiology diagram to visualize the multi-organ impact of excessive body mass and respiratory system mechanical disturbance in the context of chronic pulmonary medicine.